Marie Maerevoet

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo et al. · The Lancet Haematology · 2020 · 337 citations · Full text

Medicine, Hematology, Oncology +11

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

M. Spielmann, Henri Roché, T. Delozier et al. · Journal of Clinical Oncology · 2009 · 299 citations

Medicine, Oncology, Pharmacotherapy +17

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

Pharmacy, Hematology, Immunology +16

Multifactorial Approach to Predicting Resistance to Anthracyclines

Christine Desmedt, Angelo Di Leo, Evandro de Azambuja et al. · Journal of Clinical Oncology · 2011 · 187 citations

Medicine, Oncology, Pharmacology +16

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

Peter Vandenberghe, Lucienne Michaux, Pierre Zachée et al. · Leukemia · 2004 · 182 citations

Medicine, Molecular Biology, Pathology +8